Bristol-Myers Squibb Company (BCBA:BMY)

Argentina flag Argentina · Delayed Price · Currency is ARS
25,680
-60 (-0.23%)
Last updated: Dec 11, 2025, 3:46 PM BRT
22.72%
Market Cap149.50T
Revenue (ttm)65.83T
Net Income (ttm)8.28T
Shares Outn/a
EPS (ttm)4,071.05
PE Ratio18.06
Forward PE8.07
Dividend622.11 (2.37%)
Ex-Dividend DateOct 3, 2025
Volume431
Average Volume1,413
Open25,780
Previous Close25,740
Day's Range25,300 - 25,940
52-Week Range16,950 - 27,225
Betan/a
RSI61.50
Earnings DateFeb 5, 2026

About BCBA:BMY

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Industry Pharmaceutical Preparations
Founded 1887
Employees 34,100
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol BMY
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.